471 related articles for article (PubMed ID: 30944103)
1. Effect of recombinant human nerve growth factor eye drops in patients with dry eye: a phase IIa, open label, multiple-dose study.
Sacchetti M; Lambiase A; Schmidl D; Schmetterer L; Ferrari M; Mantelli F; Allegretti M; Garhoefer G
Br J Ophthalmol; 2020 Jan; 104(1):127-135. PubMed ID: 30944103
[TBL] [Abstract][Full Text] [Related]
2. Safety and pharmacokinetics of escalating doses of human recombinant nerve growth factor eye drops in a double-masked, randomized clinical trial.
Ferrari MP; Mantelli F; Sacchetti M; Antonangeli MI; Cattani F; D'Anniballe G; Sinigaglia F; Ruffini PA; Lambiase A
BioDrugs; 2014 Jun; 28(3):275-83. PubMed ID: 24327173
[TBL] [Abstract][Full Text] [Related]
3. Study design and baseline findings from the progression of ocular findings (PROOF) natural history study of dry eye.
McDonnell PJ; Pflugfelder SC; Stern ME; Hardten DR; Conway T; Villanueva L; Hollander DA
BMC Ophthalmol; 2017 Dec; 17(1):265. PubMed ID: 29284427
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of an enhanced viscosity artificial tear for moderate to severe dry eye disease: A multicenter, double-masked, randomized 30-day study.
Lievens C; Berdy G; Douglass D; Montaquila S; Lin H; Simmons P; Carlisle-Wilcox C; Vehige J; Haque S
Cont Lens Anterior Eye; 2019 Aug; 42(4):443-449. PubMed ID: 30573298
[TBL] [Abstract][Full Text] [Related]
5. Effectiveness of acupuncture at acupoint BL1 (Jingming) in comparison with artificial tears for moderate to severe dry eye disease: a randomized controlled trial.
Zhang X; Zhang B; Peng S; Zhang G; Ma J; Zhu W
Trials; 2022 Jul; 23(1):605. PubMed ID: 35897025
[TBL] [Abstract][Full Text] [Related]
6. Cationic Emulsion-Based Artificial Tears as a Mimic of Functional Healthy Tear Film for Restoration of Ocular Surface Homeostasis in Dry Eye Disease.
Daull P; Amrane M; Ismail D; Georgiev G; Cwiklik L; Baudouin C; Leonardi A; Garhofer G; Garrigue JS
J Ocul Pharmacol Ther; 2020; 36(6):355-365. PubMed ID: 32493105
[TBL] [Abstract][Full Text] [Related]
7. Efficacy and Safety of Artificial Tears Containing Lipidure and Hypromellose for the Treatment of Moderate Dry Eye Disease in Contact Lens Wearers.
Gagliano C; Zeppieri M; Longo A; Rubegni G; Amato R; Foti R; Cappellani F; Cocuzza M; Visalli F; Cannizzaro L; Avitabile A; Gagliano G; Lapenna L; D'Esposito F
Medicina (Kaunas); 2024 Feb; 60(2):. PubMed ID: 38399574
[No Abstract] [Full Text] [Related]
8. Efficacy of topical cyclosporine 0.05% and osmoprotective lubricating eye drops in treating dry eye disease and inflammation.
Mullick R; Annavajjhala S; Thakur P; Mohapatra A; Shetty R; D'Souza S
Indian J Ophthalmol; 2021 Dec; 69(12):3473-3477. PubMed ID: 34826977
[TBL] [Abstract][Full Text] [Related]
9. Effect of a formulated eye drop with
Tan J; Jia T; Liao R; Stapleton F
Br J Ophthalmol; 2020 Oct; 104(10):1373-1377. PubMed ID: 31949092
[TBL] [Abstract][Full Text] [Related]
10. Efficacy, safety, and acceptability of a lipid-based artificial tear formulation: a randomized, controlled, multicenter clinical trial.
Simmons PA; Carlisle-Wilcox C; Chen R; Liu H; Vehige JG
Clin Ther; 2015 Apr; 37(4):858-68. PubMed ID: 25659956
[TBL] [Abstract][Full Text] [Related]
11. Topical Low Dose Preservative-Free Hydrocortisone Reduces Signs and Symptoms in Patients with Chronic Dry Eye: A Randomized Clinical Trial.
Kallab M; Szegedi S; Hommer N; Stegmann H; Kaya S; Werkmeister RM; Schmidl D; Schmetterer L; Garhöfer G
Adv Ther; 2020 Jan; 37(1):329-341. PubMed ID: 31741283
[TBL] [Abstract][Full Text] [Related]
12. Efficacy of artificial tears containing trehalose and hyaluronic acid for dry eye disease in women aged 42-54 versus ≥ 55 years.
Mateo-Orobia AJ; Del Prado Sanz E; Blasco-Martínez A; Pablo-Júlvez LE; Farrant S; Chiambaretta F
Cont Lens Anterior Eye; 2023 Aug; 46(4):101845. PubMed ID: 37117131
[TBL] [Abstract][Full Text] [Related]
13. The feasibility of finger prick autologous blood (FAB) as a novel treatment for severe dry eye disease (DED): protocol for a randomised controlled trial.
Balal S; Udoh A; Pappas Y; Cook E; Barton G; Hassan A; Hayden K; Bourne RRA; Ahmad S; Pardhan S; Harrison M; Sharma B; Wasil M; Sharma A
BMJ Open; 2018 Oct; 8(10):e026770. PubMed ID: 30385451
[TBL] [Abstract][Full Text] [Related]
14. Efficacy of a fixed combination of 0.09 % xanthan gum/0.1 % chondroitin sulfate preservative free vs polyethylene glycol/propylene glycol in subjects with dry eye disease: a multicenter randomized controlled trial.
Pérez-Balbuena AL; Ochoa-Tabares JC; Belalcazar-Rey S; Urzúa-Salinas C; Saucedo-Rodríguez LR; Velasco-Ramos R; Suárez-Sánchez RG; Rodríguez-Carrizalez AD; Oregón-Miranda AA
BMC Ophthalmol; 2016 Sep; 16(1):164. PubMed ID: 27645318
[TBL] [Abstract][Full Text] [Related]
15. A Phase II, Multicenter, Randomized, Placebo-Controlled, Double-Masked Trial of a Topical Estradiol Ophthalmic Formulation in Postmenopausal Women with Moderate-to-Severe Dry Eye Disease.
Schmidl D; Szalai L; Kiss OG; Schmetterer L; Garhöfer G
Adv Ther; 2021 Apr; 38(4):1975-1986. PubMed ID: 33710587
[TBL] [Abstract][Full Text] [Related]
16. Reduced Efficacy of Low-dose Topical Steroids in Dry Eye Disease Associated With Graft-versus-Host Disease.
Yin J; Kheirkhah A; Dohlman T; Saboo U; Dana R
Am J Ophthalmol; 2018 Jun; 190():17-23. PubMed ID: 29572107
[TBL] [Abstract][Full Text] [Related]
17. An open-label evaluation of HP-Guar gellable lubricant eye drops for the improvement of dry eye signs and symptoms in a moderate dry eye adult population.
Hartstein I; Khwarg S; Przydryga J
Curr Med Res Opin; 2005 Feb; 21(2):255-60. PubMed ID: 15801996
[TBL] [Abstract][Full Text] [Related]
18. Randomised controlled trial of topical antibacterial Manuka (Leptospermum species) honey for evaporative dry eye due to meibomian gland dysfunction.
Albietz JM; Schmid KL
Clin Exp Optom; 2017 Nov; 100(6):603-615. PubMed ID: 28585260
[TBL] [Abstract][Full Text] [Related]
19. Efficacy of hypotonic 0.18% sodium hyaluronate eye drops in patients with dry eye disease.
Lee HS; Ji YS; Yoon KC
Cornea; 2014 Sep; 33(9):946-51. PubMed ID: 24915018
[TBL] [Abstract][Full Text] [Related]
20. Efficacy and safety of acupuncture at a single BL1 acupoint in the treatment of moderate to severe dry eye disease: Protocol for a randomized, controlled trial.
Zhang X; Liu Z; Ding W; Zhang J; Shi H; Zhu W
Medicine (Baltimore); 2018 Jun; 97(22):e10924. PubMed ID: 29851826
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
